Mette Munk Lauridsen
Overview
Explore the profile of Mette Munk Lauridsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boel F, Akimov V, Teuchler M, Terkelsen M, Wernberg C, Larsen F, et al.
Commun Med (Lond)
. 2025 Mar;
5(1):56.
PMID: 40032974
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects roughly 1 in 3 adults and is a leading cause of liver transplants and liver related mortality. A deeper understanding of disease...
2.
Aden S, Lauridsen M, Gronkjaer L
Hepatol Commun
. 2024 Nov;
8(11).
PMID: 39495144
Background: Self-management in chronic diseases like cirrhosis involves patients providing the necessary knowledge, skills, and confidence to enhance self-efficacy. This scoping review aims to describe the literature on self-management interventions...
3.
Skytthe M, Pedersen F, Wernberg C, Indira Chandran V, Krag A, Di Caterino T, et al.
Gastro Hep Adv
. 2024 Aug;
2(5):711-720.
PMID: 39129874
Background And Aims: Macrophages play an important role in the development of nonalcoholic fatty liver disease (NAFLD) and its progression to nonalcoholic steatohepatitis (NASH). In this study, we investigated the...
4.
Gairing S, Mangini C, Zarantonello L, Jonasson E, Dobbermann H, Sultanik P, et al.
JHEP Rep
. 2024 Jul;
6(8):101104.
PMID: 39035069
Background & Aims: Data on the association between proton pump inhibitor (PPI) use and hepatic encephalopathy (HE) are conflicting, and data from multicentre studies are scarce. The aim of this...
5.
Lauridsen M, Gronkjaer L, Atkins J, Mikkelsen S, Svensson T, Kimer N, et al.
Metab Brain Dis
. 2024 Jul;
39(6):1149-1155.
PMID: 39017969
Minimal hepatic encephalopathy (MHE) is common in liver cirrhosis and is identified by psychometric tests. The portosystemic hepatic encephalopathy score (PHES) is the most widely used and serves as an...
6.
Sorensen M, Lauridsen M, Montagnese S
Metab Brain Dis
. 2024 Jul;
39(6):1227-1230.
PMID: 39009929
Hepatic encephalopathy (HE) is a brain dysfunction caused by liver insufficiency with symptoms ranging from slight cognitive changes detectable only by neuropsychiatric testing to coma. Up to 60% of patients...
7.
Thomsen K, Sorensen M, Kjaergaard K, Eriksen P, Lauridsen M, Vilstrup H
Clin Liver Dis
. 2024 Jun;
28(3):541-554.
PMID: 38945642
Portal hypertension has cerebral consequences via its causes and complications, namely hepatic encephalopathy (HE), a common and devastating brain disturbance caused by liver insufficiency and portosystemic shunting. The pathogenesis involves...
8.
Juhl C, Bladbjerg E, Gram B, Knudsen T, Lauridsen M, Nygaard N, et al.
Diabetes Metab Syndr Obes
. 2024 Jun;
17:2505-2517.
PMID: 38910914
Purpose: The prevalence of obesity continues to rise. People with obesity are at increased risk of several diseases. We tested an algorithm-based screening program for people with a BMI above...
9.
Gairing S, Mangini C, Zarantonello L, Jonasson E, Danneberg S, Sultanik P, et al.
Hepatol Commun
. 2024 May;
8(5).
PMID: 38701395
Background: Minimal hepatic encephalopathy, defined by the portosystemic hepatic encephalopathy score (PHES), is associated with a higher risk of subsequent OHE. It remains unclear if there is a stepwise increase...
10.
Friis K, Thomsen K, Laleman W, Montagnese S, Vilstrup H, Lauridsen M
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202028
Transjugular intrahepatic portosystemic shunt (TIPS) is an established treatment for portal hypertension and its' complications in liver cirrhosis, yet the development of hepatic encephalopathy (HE) remains a significant concern. This...